Zimmer Biomet's shares trade on the New York Stock Exchange (NYSE) and the SIX Swiss Exchange. The ticker symbol on both exchanges is ZBH.
Zimmer Biomet's CUSIP number is: 98956P102
American Stock Transfer & Trust Company
Telephone: 888-552-8493 (toll-free)
718-921-8124 (toll / international)
Yes. Zimmer Biomet paid its initial quarterly cash dividend on April 27, 2012. Future declarations of dividends are subject to approval of the Board of Directors.
Please contact Zimmer Biomet's transfer agent, American Stock Transfer & Trust Company. Please see the Transfer Agent page for more details.
Yes. At this time, direct deposit is available only for banks located in the United States. If you wish to enroll in direct deposit, please contact Zimmer Biomet's transfer agent, American Stock Transfer & Trust Company. Please see the Transfer Agent page for more details.
Contact any stockbroker who trades on the New York Stock Exchange.
Yes. Zimmer Biomet’s Transfer Agent, American Stock Transfer & Trust Company (AST) is pleased to offer Zimmer Biomet stockholders enrollment in the Investors Choice Dividend Reinvestment and Stock Purchase Plan (Plan). The Plan provides a convenient and economical way for existing Zimmer Biomet stockholders to acquire additional shares by reinvesting cash dividends paid on Zimmer Biomet stock and/or by making optional cash purchases in accordance with the Plan’s terms and conditions. The Plan is sponsored and administered by AST, not by Zimmer Biomet.
If you are an existing Zimmer Biomet stockholder, the Plan offers you the ability to:
Stockholders are responsible for the following fees under the Plan:
Dividend Reinvestment 4% to a maximum of $2.50 for each investment
Optional Cash Purchases $2.50/transaction + $0.10/share brokerage fee
Sales $15.00/transaction + $0.10/share brokerage fee
Safekeeping $7.50 per transaction without sale
Get started today. You may enroll online at www.amstock.com. If you have questions, please contact AST via e-mail at firstname.lastname@example.org or via telephone at 888-552-8493 (toll-free in the U.S.) or 718-921-8124 (toll).
Please contact Zimmer Biomet's transfer agent, American Stock Transfer & Trust Company. AST can help with a variety of stockholder-related services. Please see the Transfer Agent page for more details.
If you own shares through a brokerage firm, you need to contact the brokerage firm directly.
Zimmer BIomet Holdings, Inc.
345 East Main Street
Warsaw, IN 46580
Zimmer Biomet’s fiscal year ends December 31.
The company operates on a calendar fiscal year which means that quarters end on the last days of March, June, September and December. Quarterly earnings releases are generally issued in the latter part of the month following each quarter's end: April, July, October and January. Please see the Financial Calendar page for more details.
No. However, Zimmer Biomet provides information on its quarterly financial performance in the form of earnings releases, earnings calls, reconciliations and Form 10-Q filings.
Color printed copies of the company's annual reports are available at no charge upon request to the Investor Relations department. Electronic copies of the color annual reports are also available in the Annual Reports section of this web site.
Reports to the SEC on Form 10-K, 10-Q, 8-K and other forms are also available at no charge upon request to the Corporate Secretary or Investor Relations departments. These reports may also be obtained electronically in the SEC Filings section of this website as well as on the SEC's website at www.sec.gov.
A spin-off occurs when one company, referred to as the parent, divests (separates) itself of one of its divisions or subsidiaries, which then becomes an independent company. In 2001, Bristol-Myers Squibb spun off Zimmer Biomet Holdings, Inc.(formerly know as Zimmer Holding, Inc.), by distributing shares of Zimmer Biomet (formerly known as Zimmer) to Bristol-Myers Squibb stockholders.
Anyone who owned Bristol-Myers Squibb shares as of July 27, 2001 received shares of Zimmer BIomet. For every 10 shares of Bristol-Myers Squibb they held, they received 1 share of Zimmer Biomet stock.
The following information about the cost basis allocation was provided by Bristol-Myers Squibb. Generally speaking, under applicable U.S. Treasury Regulations, your aggregate tax basis in your shares of Bristol-Myers Squibb common stock, as determined immediately before the distribution, must be allocated between your Zimmer BIomet common stock (including any fractional shares) and the Bristol-Myers Squibb common stock with respect to which the distribution was made. Your tax basis should be allocated in proportion to the fair market values of your Zimmer Biomet common stock and Bristol-Myers Squibb common stock as of the date of the distribution. Consequently, based on the opening reported trading prices on the New York Stock Exchange on August 7, 2001 for Bristol-Myers Squibb common stock and Zimmer Biomet common stock, Bristol-Myers Squibb believes you should allocate 4.8223% of your pre-distribution tax basis to the Zimmer Biomet common stock and 95.1777% to the Bristol-Myers Squibb common stock with respect to which the distribution was made. Please note, if you hold blocks of Bristol-Myers Squibb common stock with different tax bases, then you must allocate your U.S. Federal income tax basis on a "block-by-block" basis. Bristol-Myers Squibb Company recommends that each Bristol-Myers Squibb Company stockholder consult with his or her own tax advisor with respect to the applicability and consequences of Federal, state, local, and foreign tax laws in his or her particular situation.
If you have questions regarding your stock account or if you need stock transfer instructions, please contact Zimmer Biomet's transfer agent.
For all other inquiries, please contact Zimmer BIomet Investor Relations:
Daniel P. Florin,
Matt Abernethy, CPA
Zimmer Biomet Holdings Inc.
345 East Main Street
Warsaw, IN 46580
+1 (574) 267-6131
|Fax:||+1 (574) 372-4988|
Please submit your question using the form below. Fields marked with an * are required.